Mediating effects of insomnia and resilience on COVID-19-related post-traumatic stress disorder and quality of life in adolescents.

Publication date: Aug 02, 2024

The coronavirus disease-2019 (COVID-19) pandemic has impaired the quality of life (QoL) for many due to its extensive impacts. However, few studies have addressed the specific impact of COVID-19 on the mental health of adolescents, particularly post-traumatic stress disorder (PTSD). This study considered the impact of COVID-19-related PTSD on the QoL of adolescents in China, the mediating effects of insomnia, and the moderating effects of resilience. Participants included 50,666 adolescents aged 12-18 years selected using a comprehensive sampling method. We performed data collection from January 8th to January 18th, 2023, using the Children’s Revised Impact of Event Scale, Pittsburgh Sleep Quality Index, Ten-item Connor-Davidson Resilience Scale, and Screening for and Promotion of Health-related QoL in Children and Adolescents Questionnaire for data collection. Male adolescents exhibited significantly lower levels of PTSD and insomnia compared to females and scored significantly higher in psychological resilience and overall QoL. Insomnia played a mediating role between PTSD and QoL. Psychological resilience moderated the impact of COVID-19-related stress on adolescents’ QoL through its influence on insomnia. PTSD resulting from the COVID-19 pandemic affects the QoL of adolescents through the presence of insomnia. Psychological resilience plays a moderating role in this process. Cultivating psychological resilience in adolescents can effectively enhance their ability to cope with the impacts of sudden public events.

Open Access PDF

Concepts Keywords
China Adolescent
Coronavirus Adolescents
Females Child
Sleep China
Coronavirus disease-2019
COVID-19
Female
Humans
Insomnia
Male
Pandemics
Post-traumatic stress disorder
Quality of Life
Quality of life
Resilience
Resilience, Psychological
SARS-CoV-2
Stress Disorders, Post-Traumatic
Surveys and Questionnaires

Semantics

Type Source Name
disease MESH insomnia
disease MESH COVID-19
disease MESH post-traumatic stress disorder
disease IDO quality
pathway KEGG Coronavirus disease
disease MESH Sleep Quality
drug DRUGBANK Pentaerythritol tetranitrate
disease IDO process
drug DRUGBANK Coenzyme M
disease VO population
disease IDO symptom
disease VO Gap
disease MESH psychological stresses
drug DRUGBANK Adenosine
disease IDO history
disease MESH infection
disease MESH suicidal ideation
disease MESH sleep disorders
disease MESH complications
disease IDO susceptibility
disease VO effective
disease IDO intervention
drug DRUGBANK Trestolone
drug DRUGBANK Indoleacetic acid
disease MESH Middle East Respiratory Syndrome
disease MESH psychiatric disorders
disease MESH psychological distress
disease MESH emergency
disease VO Canada
drug DRUGBANK MK-212
drug DRUGBANK Ethanol
disease MESH suicide
disease MESH hypertension
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Copper
disease MESH myopia
disease MESH subarachnoid hemorrhage
disease MESH hepatocellular carcinoma
pathway KEGG Hepatocellular carcinoma
disease VO effectiveness
disease MESH loneliness
drug DRUGBANK Etoperidone

Original Article

(Visited 5 times, 1 visits today)